Alice Y. Ho, Gaorav Gupta, Tari A. King, Carmen A. Perez, Sujata M. Patil, Katherine H. Rogers, Yong Hannah Wen, Edi Brogi, Monica Morrow, Clifford A. Hudis, Tiffany Traina, Beryl McCormick, Simon N. Powell and Mark E. Robson Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy Cancer 118
Version of Record online: 5 MAR 2012 | DOI: 10.1002/cncr.27480
Favorable 5-year locoregional and distant control rates are achievable in patients with T1bN0 triple-negative breast cancers, approximately 66% of whom receive chemotherapy. When they receive multimodality therapy, these patients are excellent candidates for breast-conserving therapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field